undefined undefined
NaN.000
NaN.00%
M&A dealmaking in the pharmaceutical and biotechnology industry is increasing, based on the number of agreements announced in Q1 compared to the year-ago period. A new report from GlobalData found tha...
05-20 02:00
NEW YORK, May 10, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
05-11 01:51
Fusion Pharmaceuticals(FUSN.US):2024年Q1财报实现营收0美元,前值为2.8万美元,预期值为15万美元;每股收益为-0.40美...
05-07 21:20
Fusion Pharmaceuticals press release (NASDAQ:FUSN): Q1 GAAP EPS of -$0.40. Cash and Investments: As of March 31, 2024, Fusion held cash, cash equivalents and investments of $283.1 million, compared to...
05-07 19:41
Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.37) by 8.11 percent. This is a 11.11 percent increase over losses of $(0.45) per
05-07 19:08
Shares of radiopharma companies spiked Thursday as investors welcomed the latest M&A deal to hit the sector, this time between Swiss pharma giant Novartis (NYSE:NVS) and preclinical-stage biotech Mari...
05-03 02:31
NEW YORK, April 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may se...
04-27 01:56
As of April 26, 2024, four stocks in the health care sector could be flashing a...
04-26 20:09
AstraZeneca (NASDAQ:AZN) ADRs rose sharply higher in the premarket Thursday after the British drugmaker topped Street forecasts with its Q1 2024 results thanks to surging demand for its cancer drugs. ...
04-25 20:37